NIL: Nilotinib
NIL is a Ligand Of Interest in 3CS9 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3CS9_NIL_B_600 | 66% | 23% | 0.143 | 0.949 | 1.39 | 1.77 | 7 | 9 | 0 | 0 | 100% | 1 |
| 3CS9_NIL_A_600 | 64% | 35% | 0.164 | 0.962 | 1.18 | 1.38 | 5 | 6 | 0 | 0 | 100% | 1 |
| 3CS9_NIL_C_600 | 59% | 25% | 0.158 | 0.94 | 1.3 | 1.74 | 3 | 13 | 1 | 0 | 100% | 1 |
| 3CS9_NIL_D_600 | 58% | 19% | 0.142 | 0.922 | 1.47 | 1.98 | 4 | 11 | 1 | 0 | 100% | 1 |
| 3GP0_NIL_A_1 | 87% | 19% | 0.093 | 0.964 | 1.51 | 1.9 | 8 | 8 | 1 | 0 | 100% | 1 |
| 5MO4_NIL_A_601 | 80% | 21% | 0.114 | 0.962 | 1.59 | 1.73 | 5 | 8 | 2 | 0 | 100% | 1 |
